4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Phio Pharmaceuticals Corp. (PHIO) operates in the Biotechnology industry and is headquartered in King of Prussia, United States with about 6 employees. Its market capitalization is roughly $12 million. In the fiscal year ended 2025-12-31, PHIO reported $0M in revenue and ($9M) in net income.
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($9M) | ($7M) | ($11M) | ($12M) | — |
| Net Income | ($9M) | ($7M) | ($11M) | ($12M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($4M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($4M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $22M | $6M | $9M | $13M | — |
| Total Liabilities | $1M | $1M | $2M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PHIO viewer.
About TickerBase · Data methodology & sources